BUY Mankind Pharma Limited — Jay Thakkar, ICICI Securities
byJay Thakkar, ICICI SecuritiesHorizon: NA (inferred Swing (≤2wk))23 Jul 2026via Business Today
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Mankind Pharma Q1 profit rises 30%, margins expand on strong domestic business
NewsCnbc-Tv18·30 Jul · 5d ago
Mankind Pharma announced strong Q1FY27 financial results with a 13% YoY revenue growth to INR 4,031 Crore and a 25% YoY EBITDA growth to INR 1,060 Crore. PAT grew by 29% YoY. The company highlighted d
BSE · Company Update·30 Jul · 5d ago
Mankind Pharma completes sale of Broadway Hospitality stake for ₹49 crore
NewsGoogle News·27 Jul · 1w ago
2 advisors have active short-term BUY calls on this stock
Advisor consensus · adjacent horizon·7 Jul · 4w ago
Mankind Pharma Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.
NSE · Outcome of Board Meeting·30 Jul · 6d ago
Mankind Pharma Limited's Board approved the divestment of its 100% stake in Broadway Hospitality Services Private Limited and the incorporation of a wholly-owned subsidiary in Netherlands for R&D inve
NSE · Acquisition·11 Jul · 4w ago
Mankind Pharma Ltd's Board approved the incorporation of a wholly owned subsidiary in the Netherlands.
BSE · Company Update·11 Jul · 4w ago
Mankind Pharma Limited's Board approved the divestment of its 100% stake in Broadway Hospitality Services Private Limited and the incorporation of a wholly owned subsidiary in Netherlands for R&D inve
NSE · Outcome of Board Meeting·11 Jul · 4w ago
Mankind Pharma's Board approved the divestment of its 100% stake in Broadway Hospitality Services Private Limited and the incorporation of a wholly-owned subsidiary in Netherlands for R&D investments.
BSE · Others·11 Jul · 4w ago
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.